Skip to main content
Clinical Trials/CTRI/2020/06/025741
CTRI/2020/06/025741
Not yet recruiting
Phase 4

A Prospective, Randomised, Comparative clinical study to Evaluate the Efficacy and Safety of Ayurvedic Medicine Medha Vati & Allopathic Medicine Sertraline in the Management of Depression. - Medha Vati Sertraline Depression

ational Institute of Medical Sciences Research Jaipur0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
Sponsor
ational Institute of Medical Sciences Research Jaipur
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Medical Sciences Research Jaipur

Eligibility Criteria

Inclusion Criteria

  • Patients newly diagnosed as Depression of age 20\-60 years as per icd\-10 criteria with written informed consent by the patients. The HAM\-D will be used to assess the severity of Depression.

Exclusion Criteria

  • 1 Age less than 20 years and more than 60 years
  • 2 Pregnant and lactating women
  • 3 Major medical chronic disorders
  • 4 Severe depression with psychotic features or suicidal risks
  • 5 Patient who do not give consent for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials